Casandra
Casandra Test Code LC30518Version 1 (DRAFT)
Performing Lab
Tapentadol, Screen and Confirmation, Urine
Also known as: Nucynta®
Clinical Use
Order TestUse
Detect and confirm the presence of tapentadol
Special Instructions
This assay is designed for pain management. It is not intended for workplace testing and does not comply with state regulatory workplace testing programs.
Limitations
The test was developed by LabCorp and its performance characteristics were determined by the laboratory. It has not been cleared or approved by the US Food and Drug Administration (FDA). Therefore, its use is limited to clinical settings where FDA approval is not necessary.
Test Details
Methodology
Immunoassay (ELISA)
Biomarkers
2 components
Tapentadol Initial Screening • ELISAConfirmation of Positives • ELISA
LOINC Codes
Order Codes
- 72485-6
Result Codes
- 72485-6
Result Turnaround Time
3-5 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Urine
Volume
20 mL
Minimum Volume
Not provided
Container
Plastic urine container
Storage Instructions
Maintain specimen at room temperature. If arrival at lab will extend beyond seven days, refrigerate.
